US 11958908
Compositions and methods for the depletion of CD117+ cells
granted A61KA61K2035/124A61K2039/505
Quick answer
US patent 11958908 (Compositions and methods for the depletion of CD117+ cells) held by CRISPR THERAPEUTICS AG expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2035/124, A61K2039/505, A61K35/545, A61K38/00